{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T17:41:28Z","timestamp":1780508488000,"version":"3.54.1"},"reference-count":25,"publisher":"Society of Nuclear Medicine","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Nucl. Med. Technol."],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.2967\/jnmt.123.265416","type":"journal-article","created":{"date-parts":[[2023,6,2]],"date-time":"2023-06-02T14:10:34Z","timestamp":1685715034000},"page":"90-98","source":"Crossref","is-referenced-by-count":13,"title":["Cardiac Amyloidosis Imaging, Part 2: Quantification and Technical Considerations"],"prefix":"10.2967","volume":"51","author":[{"given":"Eric J.","family":"Schockling","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Beth","family":"Farrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Embry-Dierson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime","family":"Warren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Jerome","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2023,6,2]]},"reference":[{"key":"2023061207251115000_51.2.90.1","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.120.245381"},{"key":"2023061207251115000_51.2.90.2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(19)33478-3"},{"key":"2023061207251115000_51.2.90.3","first-page":"83","article-title":"Cardiac amyloidosis imaging, part 1: etiology and acquisition","volume":"51","author":"Embry-Dierson","year":"2023","journal-title":"J Nucl Technol Imaging."},{"key":"2023061207251115000_51.2.90.4","doi-asserted-by":"publisher","DOI":"10.2967\/jnmt.123.265492"},{"key":"2023061207251115000_51.2.90.5","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.121.263507"},{"key":"2023061207251115000_51.2.90.6","first-page":"e000029","article-title":"ASNC\/AHA\/ASE\/EANM\/HFSA\/ISA\/SCMR\/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: part 1 of 2\u2014evidence base and standardized methods of imaging","volume":"14","author":"Dorbala","year":"2021","journal-title":"Circ Cardiovasc Imaging."},{"key":"2023061207251115000_51.2.90.7","doi-asserted-by":"publisher","DOI":"10.1161\/cir.0000000000000792"},{"key":"2023061207251115000_51.2.90.8","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1007\/s12350-018-01552-4","article-title":"State-of-the-art radionuclide imaging in cardiac transthyretin amyloidosis","volume":"26","author":"Singh","year":"2019","journal-title":"J Nucl Cardiol."},{"key":"2023061207251115000_51.2.90.9","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1987.00370060035007"},{"key":"2023061207251115000_51.2.90.10","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s12350-013-9803-2","article-title":"Nuclear imaging modalities for cardiac amyloidosis","volume":"21","author":"Bokhari","year":"2014","journal-title":"J Nucl Cardiol."},{"key":"2023061207251115000_51.2.90.11","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1007\/s12350-020-02455-z","article-title":"Addendum to ASNC\/AHA\/ASE\/EANM\/HFSA\/ISA\/SCMR\/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: part 1 of 2\u2014evidence base and standardized methods of imaging","volume":"28","author":"Dorbala","year":"2021","journal-title":"J Nucl Cardiol."},{"key":"2023061207251115000_51.2.90.12","doi-asserted-by":"publisher","DOI":"10.2967\/jnmt.122.264895"},{"key":"2023061207251115000_51.2.90.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2005.05.073"},{"key":"2023061207251115000_51.2.90.14","unstructured":"ASNC cardiac amyloidosis practice points: 99mtechnetium-pyrophosphate imaging for transthyretin cardiac amyloidosis. American Society of Nuclear Cardiology website. https:\/\/www.asnc.org\/files\/19110%20ASNC%20Amyloid%20Practice%20Points%20WEB.pdf. Published February 2016. Updated February 2019. Accessed April 10, 2023."},{"key":"2023061207251115000_51.2.90.15","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.116.021612"},{"key":"2023061207251115000_51.2.90.16","unstructured":"Transthyretin cardiac amyloidosis: frequently asked questions. American Society of Nuclear Cardiology website. https:\/\/www.asnc.org\/files\/transthyretin_FAQ.pdf. Published July 2021. Accessed April 10, 2023."},{"key":"2023061207251115000_51.2.90.17","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1007\/s12350-020-02273-3","article-title":"Tc-99m-PYP imaging for cardiac amyloidosis: defining the best protocol before the flood gates burst","volume":"27","author":"Bokhari","year":"2020","journal-title":"J Nucl Cardiol."},{"key":"2023061207251115000_51.2.90.18","unstructured":"Technescan PYP Kit for the Preparation of Technetium 99m99mTc Pyrophosphate Injection RX Only . Mallinckrodt; 2016."},{"key":"2023061207251115000_51.2.90.19","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s12350-020-02340-9","article-title":"Quantification of amyloid deposition using bone scan agents","volume":"29","author":"Kudo","year":"2022","journal-title":"J Nucl Cardiol."},{"key":"2023061207251115000_51.2.90.20","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s12350-020-02503-8","article-title":"Optimal interpretation of Tc99m PYP in 2020: avoiding the million-dollar mistake","volume":"28","author":"Gerber","year":"2021","journal-title":"J Nucl Cardiol."},{"key":"2023061207251115000_51.2.90.21","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/s12350-020-02328-5","article-title":"Comparison of planar with tomographic pyrophosphate scintigraphy for transthyretin cardiac amyloidosis: perils and pitfalls","volume":"28","author":"Asif","year":"2021","journal-title":"J Nucl Cardiol."},{"key":"2023061207251115000_51.2.90.22","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1007\/s12350-020-02205-1","article-title":"99mTc-pyrophosphate scintigraphy for the diagnosis of cardiac ATTR: comparison of quantitative and semi-quantitative approaches","volume":"27","author":"R\u00e9gis","year":"2020","journal-title":"J Nucl Cardiol."},{"key":"2023061207251115000_51.2.90.23","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1007\/s12350-020-02139-8","article-title":"Technetium pyrophosphate nuclear scintigraphy for cardiac amyloidosis: imaging at 1 vs 3 hours and planar vs SPECT\/CT","volume":"27","author":"Sperry","year":"2020","journal-title":"J Nucl Cardiol."},{"key":"2023061207251115000_51.2.90.24","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1007\/s12350-021-02563-4","article-title":"Diagnostic and prognostic value of technetium-99m pyrophosphate uptake quantitation for transthyretin cardiac amyloidosis","volume":"28","author":"Miller","year":"2021","journal-title":"J Nucl Cardiol."},{"key":"2023061207251115000_51.2.90.25","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1007\/s12350-021-02806-4","article-title":"Quantitative technetium pyrophosphate and cardiovascular magnetic resonance in patients with suspected cardiac amyloidosis","volume":"29","author":"Roshankar","year":"2022","journal-title":"J Nucl Cardiol."}],"container-title":["Journal of Nuclear Medicine Technology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnmt.123.265416","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,12]],"date-time":"2023-06-12T14:27:50Z","timestamp":1686580070000},"score":1,"resource":{"primary":{"URL":"http:\/\/tech.snmjournals.org\/lookup\/doi\/10.2967\/jnmt.123.265416"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":25,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,6,2]]},"published-print":{"date-parts":[[2023,6]]}},"alternative-id":["10.2967\/jnmt.123.265416"],"URL":"https:\/\/doi.org\/10.2967\/jnmt.123.265416","relation":{},"ISSN":["0091-4916","1535-5675"],"issn-type":[{"value":"0091-4916","type":"print"},{"value":"1535-5675","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6]]}}}